KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

November 19 Emerging Late Effects of Targeted Molecular...

  1. Rich&Poor
    1,135 Posts.
    lightbulb Created with Sketch. 815
    clock Created with Sketch.
    13/08/20
    13:03
    Post #: 46510406
    November 19 Emerging Late Effects of Targeted Molecular Therapies Eric Chow, MD, MPH, could be relevant to Paxalisib regarding DIPG.

    Regards.
    KZA Price at posting: 79.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.